UBS Oncology Impact Fund, 10% Owner: Werewolf Therapeutics HOWL Sell · Filed 25/10/29

Trade details

Type: Insider sale
Amount: $208,072
Shares · price: 134,240 sh · $1.55 a share
Held after: 6,442,653 sh
Stock: Werewolf Therapeutics HOWL
Person: UBS Oncology Impact Fund10% Owner
Trade date: 25/10/29
Filed: 25/10/29
Days to filing: 0 days

Sold 2.0% of holdings

Share of holding sold: 2.0%

Werewolf Therapeutics trades, last 26 weeks

What else happened in Werewolf Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/29~25/11/28

UBS Oncology Impact Fund's recent trades

UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$27.3K
80,142 sh
$27.3K
Filed 07/06
Traded 07/06
UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$28.4K
87,916 sh
$28.4K
Filed 06/29
Traded 06/29
UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$99K
202,029 sh
$99K
Filed 05/28
Traded 05/28
UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$123.8K
240,280 sh
$123.8K
Filed 05/18
Traded 05/18
UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$47.5K
69,904 sh
$47.5K
Filed 05/11
Traded 05/11